{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T10:22:40Z","timestamp":1793701360049,"version":"4.5.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2018R1A5A2025079"],"award-info":[{"award-number":["2018R1A5A2025079"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2020M3A9E4038694"],"award-info":[{"award-number":["2020M3A9E4038694"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:italic>Lactobacillus<\/jats:italic> is a probiotic with therapeutic potential for several diseases, including liver disease. However, the therapeutic effect of <jats:italic>L. plantarum<\/jats:italic> against nonalcoholic steatohepatitis (NASH) and its underlying mechanisms remain unelucidated. Therefore, we delineated the <jats:italic>L. plantarum-<\/jats:italic>mediated NASH regulation in a mouse model to understand its therapeutic effect. We used a choline-deficient high-fat diet (CD-HFD)-induced murine model that recapitulated the critical features of human metabolic syndrome and investigated the effect of <jats:italic>L. plantarum<\/jats:italic> on NASH pathogenesis using transcriptomic, metagenomic, and immunohistochemistry analyses. Validation experiments were performed using liver organoids and a murine model fed a methionine-choline-deficient (MCD) diet. <jats:italic>L. plantarum<\/jats:italic> treatment in mice significantly decreased liver inflammation and improved metabolic phenotypes, such as insulin tolerance and the hepatic lipid content, compared with those in the vehicle group. RNA-sequencing analysis revealed that <jats:italic>L. plantarum<\/jats:italic> treatment significantly downregulated inflammation-related pathways. Shotgun metagenomic analysis revealed that L-arginine biosynthesis-related microbial genes were significantly upregulated in the <jats:italic>L. plantarum<\/jats:italic> group. We also confirmed the elevated arginine levels in the serum of the <jats:italic>L. plantarum<\/jats:italic> group. We further used liver organoids and mice fed an MCD diet to demonstrate that L-arginine alone was sufficient to alleviate liver inflammation. Our data revealed a novel and counterintuitive therapeutic effect of <jats:italic>L. plantarum<\/jats:italic> on alleviating NASH-related liver inflammation by increasing circulating L-arginine.<\/jats:p>","DOI":"10.1038\/s12276-023-01102-0","type":"journal-article","created":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T01:02:28Z","timestamp":1698800548000},"page":"2332-2345","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Lactobacillus plantarum ameliorates NASH-related inflammation by upregulating l-arginine production"],"prefix":"10.1038","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2471-3385","authenticated-orcid":false,"given":"Dong Yun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6324-2224","authenticated-orcid":false,"given":"Jun Yong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8741-6177","authenticated-orcid":false,"given":"Heon Yung","family":"Gee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,1]]},"reference":[{"key":"1102_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi, Z. et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat. Rev. Gastroenterol. Hepatol. 15, 11\u201320 (2018).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"1102_CR2","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1146\/annurev-pathol-020117-043617","volume":"13","author":"JP Arab","year":"2018","unstructured":"Arab, J. P., Arrese, M. & Trauner, M. Recent insights into the pathogenesis of nonalcoholic fatty liver disease. Annu. Rev. Pathol. 13, 321\u2013350 (2018).","journal-title":"Annu. Rev. Pathol."},{"key":"1102_CR3","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1002\/hep.25762","volume":"55","author":"N Chalasani","year":"2012","unstructured":"Chalasani, N. et al. The diagnosis and management of non\u2010alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 55, 2005\u20132023 (2012).","journal-title":"Hepatology"},{"key":"1102_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cld.2017.08.003","volume":"22","author":"CC Lindenmeyer","year":"2018","unstructured":"Lindenmeyer, C. C. & McCullough, A. J. The natural history of nonalcoholic fatty liver disease\u2014an evolving view. Clin. Liver Dis. 22, 11\u201321 (2018).","journal-title":"Clin. Liver Dis."},{"key":"1102_CR5","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/nrgastro.2016.3","volume":"13","author":"ME Rinella","year":"2016","unstructured":"Rinella, M. E. & Sanyal, A. J. Management of NAFLD: a stage-based approach. Nat. Rev. Gastroenterol. Hepatol. 13, 196\u2013205 (2016).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"1102_CR6","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver (EASL),* European Association for the Study of Diabetes (EASD), & European Association for the Study of Obesity (EASO) EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. Obes. Facts 9, 65\u201390 (2016).","DOI":"10.1159\/000443344"},{"key":"1102_CR7","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3350\/cmh.2021.0178","volume":"27","author":"SH Kang","year":"2021","unstructured":"Kang, S. H. et al. KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease. Clin. Mol. Hepatol. 27, 363 (2021).","journal-title":"Clin. Mol. Hepatol."},{"key":"1102_CR8","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/nrgastro.2016.85","volume":"13","author":"C Leung","year":"2016","unstructured":"Leung, C., Rivera, L., Furness, J. B. & Angus, P. W. The role of the gut microbiota in NAFLD. Nat. Rev. Gastroenterol. Hepatol. 13, 412\u2013425 (2016).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"1102_CR9","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/s41591-019-0439-x","volume":"25","author":"J Suez","year":"2019","unstructured":"Suez, J., Zmora, N., Segal, E. & Elinav, E. The pros, cons, and many unknowns of probiotics. Nat. Med. 25, 716\u2013729 (2019).","journal-title":"Nat. Med."},{"key":"1102_CR10","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nature23874","volume":"549","author":"LJ Cohen","year":"2017","unstructured":"Cohen, L. J. et al. Commensal bacteria make GPCR ligands that mimic human signalling molecules. Nature 549, 48\u201353 (2017).","journal-title":"Nature"},{"key":"1102_CR11","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jhep.2017.11.014","volume":"68","author":"F Marra","year":"2018","unstructured":"Marra, F. & Svegliati-Baroni, G. Lipotoxicity and the gut-liver axis in NASH pathogenesis. J. Hepatol. 68, 280\u2013295 (2018).","journal-title":"J. Hepatol."},{"key":"1102_CR12","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3389\/fimmu.2019.00277","volume":"10","author":"D Parada Venegas","year":"2019","unstructured":"Parada Venegas, D. et al. Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Front. Immunol. 10, 277 (2019).","journal-title":"Front. Immunol."},{"key":"1102_CR13","doi-asserted-by":"publisher","first-page":"4299","DOI":"10.1039\/C8FO00349A","volume":"9","author":"L Qiu","year":"2018","unstructured":"Qiu, L., Tao, X., Xiong, H., Yu, J. & Wei, H. Lactobacillus plantarum ZDY04 exhibits a strain-specific property of lowering TMAO via the modulation of gut microbiota in mice. Food Funct. 9, 4299\u20134309 (2018).","journal-title":"Food Funct."},{"key":"1102_CR14","doi-asserted-by":"publisher","first-page":"949","DOI":"10.3390\/nu10070949","volume":"10","author":"AM Barnett","year":"2018","unstructured":"Barnett, A. M., Roy, N. C., Cookson, A. L. & McNabb, W. C. Metabolism of caprine milk carbohydrates by probiotic bacteria and Caco-2: HT29\u2013MTX epithelial co-cultures and their impact on intestinal barrier integrity. Nutrients 10, 949 (2018).","journal-title":"Nutrients"},{"key":"1102_CR15","doi-asserted-by":"crossref","unstructured":"Behera, S. S., Ray, R. C. & Zdolec, N. Lactobacillus plantarum with functional properties: an approach to increase safety and shelf-life of fermented foods. Biomed. Res. Int. 2018, 9361614 (2018).","DOI":"10.1155\/2018\/9361614"},{"key":"1102_CR16","doi-asserted-by":"publisher","first-page":"5843","DOI":"10.1007\/s00253-019-09703-4","volume":"103","author":"Z Zhao","year":"2019","unstructured":"Zhao, Z. et al. Lactobacillus plantarum NA136 improves the non-alcoholic fatty liver disease by modulating the AMPK\/Nrf2 pathway. Appl. Microbiol. Biotechnol. 103, 5843\u20135850 (2019).","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"1102_CR17","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3350\/cmh.2020.0125","volume":"27","author":"NY Lee","year":"2021","unstructured":"Lee, N. Y. et al. Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis. Clin. Mol. Hepatol. 27, 110 (2021).","journal-title":"Clin. Mol. Hepatol."},{"key":"1102_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 1\u201321 (2014).","journal-title":"Genome Biol."},{"key":"1102_CR19","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1111\/apt.13376","volume":"42","author":"A Wieland","year":"2015","unstructured":"Wieland, A., Frank, D., Harnke, B. & Bambha, K. Systematic review: microbial dysbiosis and nonalcoholic fatty liver disease. Aliment. Pharmacol. Ther. 42, 1051\u20131063 (2015).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"1102_CR20","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1369\/0022155414545787","volume":"62","author":"R Lattouf","year":"2014","unstructured":"Lattouf, R. et al. Picrosirius red staining: a useful tool to appraise collagen networks in normal and pathological tissues. J. Histochem. Cytochem. 62, 751\u2013758 (2014).","journal-title":"J. Histochem. Cytochem."},{"key":"1102_CR21","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1242\/dmm.006239","volume":"3","author":"JE Ayala","year":"2010","unstructured":"Ayala, J. E. et al. Standard operating procedures for describing and performing metabolic tests of glucose homeostasis in mice. Dis. Model. Mech. 3, 525\u2013534 (2010).","journal-title":"Dis. Model. Mech."},{"key":"1102_CR22","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1002\/hep.22569","volume":"48","author":"O Cheung","year":"2008","unstructured":"Cheung, O. et al. Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression. Hepatology 48, 1810\u20131820 (2008).","journal-title":"Hepatology"},{"key":"1102_CR23","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1053\/j.gastro.2016.02.073","volume":"150","author":"NS Betrapally","year":"2016","unstructured":"Betrapally, N. S., Gillevet, P. M. & Bajaj, J. S. Changes in the intestinal microbiome and alcoholic and nonalcoholic liver diseases: causes or effects? Gastroenterology 150, 1745\u20131755.e1743 (2016).","journal-title":"Gastroenterology"},{"key":"1102_CR24","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/hep.26093","volume":"57","author":"L Zhu","year":"2013","unstructured":"Zhu, L. et al. Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH. Hepatology 57, 601\u2013609 (2013).","journal-title":"Hepatology"},{"key":"1102_CR25","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.celrep.2015.07.042","volume":"12","author":"RM Jones","year":"2015","unstructured":"Jones, R. M. et al. Lactobacilli modulate epithelial cytoprotection through the Nrf2 pathway. Cell Rep. 12, 1217\u20131225 (2015).","journal-title":"Cell Rep."},{"key":"1102_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-9255-7-15","volume":"7","author":"AL Harte","year":"2010","unstructured":"Harte, A. L. et al. Elevated endotoxin levels in non-alcoholic fatty liver disease. J. Inflamm. 7, 1\u201310 (2010).","journal-title":"J. Inflamm."},{"key":"1102_CR27","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/jpen.1496","volume":"43","author":"D Zhang","year":"2019","unstructured":"Zhang, D., Wen, J., Zhou, J., Cai, W. & Qian, L. Milk fat globule membrane ameliorates necrotizing enterocolitis in neonatal rats and suppresses lipopolysaccharide\u2010induced inflammatory response in IEC\u20106 enterocytes. JPEN J. Parenter. Enter. Nutr. 43, 863\u2013873 (2019).","journal-title":"JPEN J. Parenter. Enter. Nutr."},{"key":"1102_CR28","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman, S. L., Neuschwander-Tetri, B. A., Rinella, M. & Sanyal, A. J. Mechanisms of NAFLD development and therapeutic strategies. Nat. Med. 24, 908\u2013922 (2018).","journal-title":"Nat. Med."},{"key":"1102_CR29","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/MOG.0b013e32834e7b4b","volume":"28","author":"KD Corbin","year":"2012","unstructured":"Corbin, K. D. & Zeisel, S. H. Choline metabolism provides novel insights into non-alcoholic fatty liver disease and its progression. Curr. Opin. Gastroenterol. 28, 159 (2012).","journal-title":"Curr. Opin. Gastroenterol."},{"key":"1102_CR30","doi-asserted-by":"publisher","first-page":"5273","DOI":"10.1007\/s00253-020-10633-9","volume":"104","author":"Z Zhao","year":"2020","unstructured":"Zhao, Z. et al. Lactobacillus plantarum NA136 ameliorates nonalcoholic fatty liver disease by modulating gut microbiota, improving intestinal barrier integrity, and attenuating inflammation. Appl. Microbiol. Biotechnol. 104, 5273\u20135282 (2020).","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"1102_CR31","doi-asserted-by":"publisher","first-page":"542","DOI":"10.3390\/nu12020542","volume":"12","author":"E-J Park","year":"2020","unstructured":"Park, E.-J. et al. Beneficial effects of Lactobacillus plantarum strains on non-alcoholic fatty liver disease in high fat\/high fructose diet-fed rats. Nutrients 12, 542 (2020).","journal-title":"Nutrients"},{"key":"1102_CR32","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.mib.2015.10.005","volume":"29","author":"M Gogoi","year":"2016","unstructured":"Gogoi, M., Datey, A., Wilson, K. T. & Chakravortty, D. Dual role of arginine metabolism in establishing pathogenesis. Curr. Opin. Microbiol. 29, 43\u201348 (2016).","journal-title":"Curr. Opin. Microbiol."},{"key":"1102_CR33","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3945\/an.116.012971","volume":"8","author":"Y Hou","year":"2017","unstructured":"Hou, Y. & Wu, G. Nutritionally nonessential amino acids: a misnomer in nutritional sciences. Adv. Nutr. 8, 137\u2013139 (2017).","journal-title":"Adv. Nutr."},{"key":"1102_CR34","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.jnutbio.2005.12.001","volume":"17","author":"WS Jobgen","year":"2006","unstructured":"Jobgen, W. S., Fried, S. K., Fu, W. J., Meininger, C. J. & Wu, G. Regulatory role for the arginine\u2013nitric oxide pathway in metabolism of energy substrates. J. Nutr. Biochem. 17, 571\u2013588 (2006).","journal-title":"J. Nutr. Biochem."},{"key":"1102_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bj3360001","volume":"336","author":"G Wu","year":"1998","unstructured":"Wu, G. & Morris, S. M. Jr Arginine metabolism: nitric oxide and beyond. Biochem. J. 336, 1\u201317 (1998).","journal-title":"Biochem. J."},{"key":"1102_CR36","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1128\/jb.179.8.2697-2706.1997","volume":"179","author":"F Bringel","year":"1997","unstructured":"Bringel, F., Frey, L., Boivin, S. & Hubert, J. C. Arginine biosynthesis and regulation in Lactobacillus plantarum: the carA gene and the argCJBDF cluster are divergently transcribed. J. Bacteriol. 179, 2697\u20132706 (1997).","journal-title":"J. Bacteriol."},{"key":"1102_CR37","doi-asserted-by":"publisher","first-page":"6059","DOI":"10.1128\/JB.186.18.6059-6069.2004","volume":"186","author":"H Nicoloff","year":"2004","unstructured":"Nicoloff, H., Arsene-Ploetze, F., Malandain, C., Kleerebezem, M. & Bringel, F. Two arginine repressors regulate arginine biosynthesis in Lactobacillus plantarum. J. Bacteriol. 186, 6059\u20136069 (2004).","journal-title":"J. Bacteriol."},{"key":"1102_CR38","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s00726-008-0184-9","volume":"37","author":"J Han","year":"2009","unstructured":"Han, J. et al. Dietary L-arginine supplementation alleviates immunosuppression induced by cyclophosphamide in weaned pigs. Amino Acids 37, 643\u2013651 (2009).","journal-title":"Amino Acids"},{"key":"1102_CR39","doi-asserted-by":"crossref","unstructured":"Wu, T. et al. Arginine relieves the inflammatory response and enhances the casein expression in bovine mammary epithelial cells induced by lipopolysaccharide. Mediat. Inflamm. 2016, 9618795 (2016).","DOI":"10.1155\/2016\/9618795"},{"key":"1102_CR40","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.2353\/ajpath.2008.071009","volume":"172","author":"K Hnia","year":"2008","unstructured":"Hnia, K. et al. L-arginine decreases inflammation and modulates the nuclear factor-\u03baB\/matrix metalloproteinase cascade in mdx muscle fibers. Am. J. Pathol. 172, 1509\u20131519 (2008).","journal-title":"Am. J. Pathol."},{"key":"1102_CR41","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1021\/acs.jafc.9b07611","volume":"68","author":"J Lan","year":"2020","unstructured":"Lan, J. et al. L-arginine ameliorates lipopolysaccharide-induced intestinal inflammation through inhibiting the TLR4\/NF-\u03baB and MAPK pathways and stimulating \u03b2-defensin expression in vivo and in vitro. J. Agric. Food Chem. 68, 2648\u20132663 (2020).","journal-title":"J. Agric. Food Chem."},{"key":"1102_CR42","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1172\/JCI0216143","volume":"110","author":"WJ de Jonge","year":"2002","unstructured":"de Jonge, W. J. et al. Arginine deficiency affects early B cell maturation and lymphoid organ development in transgenic mice. J. Clin. Invest. 110, 1539\u20131548 (2002).","journal-title":"J. Clin. Invest."},{"key":"1102_CR43","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1017\/S000711450769936X","volume":"98","author":"P Li","year":"2007","unstructured":"Li, P., Yin, Y.-L., Li, D., Kim, S. W. & Wu, G. Amino acids and immune function. Br. J. Nutr. 98, 237\u2013252 (2007).","journal-title":"Br. J. Nutr."},{"key":"1102_CR44","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.jss.2008.07.002","volume":"155","author":"RO Giovanardi","year":"2009","unstructured":"Giovanardi, R. O., Rhoden, E. L., Cerski, C. T., Salvador, M. & Kalil, A. N. Pharmacological preconditioning using intraportal infusion of L-arginine protects against hepatic ischemia reperfusion injury. J. Surg. Res. 155, 244\u2013253 (2009).","journal-title":"J. Surg. Res."},{"key":"1102_CR45","first-page":"421","volume":"120","author":"P Muriel","year":"1998","unstructured":"Muriel, P. & Gonz\u00e1lez, P. Liver damage induced by acute cholestasis in the rat is ameliorated partially by L-arginine. Comp. Biochem. Physiol. Part C: Pharmacol. Toxicol. Endocrinol. 120, 421\u2013424 (1998).","journal-title":"Comp. Biochem. Physiol. Part C: Pharmacol. Toxicol. Endocrinol."},{"key":"1102_CR46","doi-asserted-by":"publisher","first-page":"e0174441","DOI":"10.1371\/journal.pone.0174441","volume":"12","author":"Q Meng","year":"2017","unstructured":"Meng, Q., Cooney, M., Yepuri, N. & Cooney, R. N. L-arginine attenuates Interleukin-1\u03b2 (IL-1\u03b2) induced Nuclear Factor Kappa-Beta (NF-\u03baB) activation in Caco-2 cells. PLoS ONE 12, e0174441 (2017).","journal-title":"PLoS ONE"},{"key":"1102_CR47","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.bbamem.2004.04.001","volume":"1664","author":"R Visigalli","year":"2004","unstructured":"Visigalli, R. et al. The stimulation of arginine transport by TNF\u03b1 in human endothelial cells depends on NF-\u03baB activation. Biochim. Biophy. Acta (BBA)-Biomembr. 1664, 45\u201352 (2004).","journal-title":"Biochim. Biophy. Acta (BBA)-Biomembr."},{"key":"1102_CR48","doi-asserted-by":"crossref","unstructured":"Liu, Z. et al. Lactobacillus plantarum 23-1 improves intestinal inflammation and barrier function through the TLR4\/NF-\u03baB signaling pathway in obese mice. Food Funct. 13, 5971-5986 (2022).","DOI":"10.1039\/D1FO04316A"},{"key":"1102_CR49","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.3389\/fmicb.2018.01953","volume":"9","author":"J Wang","year":"2018","unstructured":"Wang, J. et al. Probiotic Lactobacillus plantarum promotes intestinal barrier function by strengthening the epithelium and modulating gut microbiota. Front. Microbiol. 9, 1953 (2018).","journal-title":"Front. Microbiol."},{"key":"1102_CR50","doi-asserted-by":"publisher","first-page":"1673S","DOI":"10.1093\/jn\/137.6.1673S","volume":"137","author":"G Wu","year":"2007","unstructured":"Wu, G. et al. Pharmacokinetics and safety of arginine supplementation in animals. J. Nutr. 137, 1673S\u20131680S (2007).","journal-title":"J. Nutr."},{"key":"1102_CR51","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.2337\/db06-1595","volume":"56","author":"DM Tsukumo","year":"2007","unstructured":"Tsukumo, D. M. et al. Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes 56, 1986\u20131998 (2007).","journal-title":"Diabetes"},{"key":"1102_CR52","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1053\/j.gastro.2010.03.052","volume":"139","author":"K Miura","year":"2010","unstructured":"Miura, K. et al. Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1\u03b2 in mice. Gastroenterology 139, 323\u2013334. e327 (2010).","journal-title":"Gastroenterology"},{"key":"1102_CR53","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nature10809","volume":"482","author":"J Henao-Mejia","year":"2012","unstructured":"Henao-Mejia, J. et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482, 179\u2013185 (2012).","journal-title":"Nature"},{"key":"1102_CR54","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.jhepr.2019.09.001","volume":"1","author":"V M\u00e4nnist\u00f6","year":"2019","unstructured":"M\u00e4nnist\u00f6, V. et al. Serum lipopolysaccharides predict advanced liver disease in the general population. JHEP Rep. 1, 345\u2013352 (2019).","journal-title":"JHEP Rep."}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s12276-023-01102-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-023-01102-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-023-01102-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T05:03:17Z","timestamp":1701406997000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-023-01102-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,1]]},"references-count":54,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,11]]}},"alternative-id":["1102"],"URL":"https:\/\/doi.org\/10.1038\/s12276-023-01102-0","relation":{},"ISSN":["2092-6413"],"issn-type":[{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,1]]},"assertion":[{"value":"8 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}